The Khavinson Lineage: 50 Years of Bioregulator Research

The St. Petersburg Institute of Bioregulation and Gerontology, founded by Vladimir Khavinson, has produced over 800 peer-reviewed publications on short-chain peptide bioregulators since the 1970s. The body of work spans organ-specific peptide bioregulators, age-related decline modeling, and longevity outcomes in human cohorts.

Origin of the field

Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology began systematic research on short-chain peptide bioregulators in the 1970s, initially within the framework of military performance medicine. The body of work expanded into civilian gerontology research over the following decades.

Publication scope

The institute has produced over 800 peer-reviewed publications on peptide bioregulators across PubMed-indexed journals, including organ-specific bioregulators (pineal, thymic, vascular, pancreatic, hepatic) and broader pathway-modulating compounds. The publication rate continues at present.

Key compounds in the lineage

AEDG (Epitalon, pineal), KED (vascular), GHK (which Khavinson research extended beyond Pickart's original characterization), and dozens of other tetrapeptide and tripeptide compounds have been characterized through this lineage.

Western research integration

Independent confirmation of Khavinson lineage findings has been published by Western institutions including Brunel University London (2025 hTERT confirmation) and groups working on Pickart's original GHK characterization since 1973.

Citations

  1. Khavinson VKh. Peptides and ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144.
  2. Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139-49.
Join the Early Access List